Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018

Date: April 15, 2018
Pages: 70
US$ 2,650.00 US$ 2,200.00 (This month only)
License [?]:
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: H3334004D50EN

Download PDF Leaflet

Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018

The report generally describes heparin sodium, examines its uses, production methods, patents. Heparin sodium market situation is overviewed; heparin sodium manufacturers and suppliers with contacts and product range are mentioned in the study.

Furthermore, heparin sodium prices in regional markets can be found in the report with regards to countries and companies.

The report also focuses on heparin sodium consumers by providing data on companies that use it.

Our research team can evaluate the following positions for each chemical product in any country or region:

  • present market conditions
  • plants’ capacity and production
  • amount and structure of demand
  • export and import
  • market prices trends
  • existing technologies an patents
  • raw materials market
  • market forecast
  • etc.
Thus, Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018 can present:
  • heparin sodium ranges, trademarks, analogous products, application areas, manufacturing methods
  • present heparin sodium market conditions, prices
  • heparin sodium market forecast, estimations
  • heparin sodium manufacturers, consumers and traders (including contact details)

Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018 contents were worked out and placed on the website in April, 2018. As a special offer the report price was brought down and now is as low as US$ 2,200.00. Do not lose the chance to order this Market Report for almost half-price.

1. HEPARIN SODIUM (CAS 9041-08-1)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information


2.1. Heparin sodium application spheres, downstream products



Summary of the invention
Detailed description of the invention


5.1. General heparin sodium market situation, trends
5.2. Manufacturers of heparin sodium
  - Europe
  - Asia
  - North America
  - Other regions
5.3. Heparin sodium suppliers (importers, local distributors)
  - Europe
  - Asia
  - North America
  - Other regions
5.4. Heparin sodium market forecast


6.1. Heparin sodium prices in Europe
6.2. Heparin sodium prices in Asia
6.3. Heparin sodium prices in North America
6.4. Heparin sodium prices in other regions


7.1. Heparin sodium market by application sphere
7.2. Heparin sodium downstream markets trends and prospects
7.3. Heparin sodium consumers globally
  - Europe
  - Asia
  - North America
  - Other regions

*Please note that Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.
Product Name:Heparin sodium
  • Ardeparin sodium
  • Dalteparin sodium
  • Enoxaparin sodium
  • Heparin,compounds,sodium salt
  • Heparin
  • Heparin Sodium
  • Sodium acid heparin
  • Heparin Sodium BP
  • Heparin sodium,low molecular weight heparins
Structure: (CAS 9041-08-1)
Appearance:Odorless white to off-white solid or liquid
Usage:Anticlotting agent.

Heparin sodium (Alfa87-120; Alfa 87-163; Alfa 87-198; Alfa 87-81; Alfa 88-247; Ardeparin sodium; Badyket; Clivarin 1750; Fragmin; Fragmin IV; H 2149; Hed-Heparin; Hepaflush; Hepagumin; Hepalean; Heparin Fragment Kabi 2165; Heparin sodium; HeparineChoay; Heprinar; Hepsal; Ivor; Kabi 2165; LHN 1; Lioton1000; etc.) refers to a complex glycosaminoglycan that is composed of alternate sequences of uronic acid -D-glucosamine linked by bonds. In heparin sodium, the acidic protons of the sulfate units are partially replaced by sodium ions.

Heparin sodium is a white odorless solid with the molecular formula (C12H16NS2Na3)20. The product is 5% soluble in water.

Heparin sodium exhibits a lot of uses, however, it is most widely used as an anticoagulant. The product is utilized to prevent or decrease blood clotting during different kinds of surgeries and during dialysis. Heparin sodium prevents clots of blood from forming and becoming larger. Furthermore, the product is used in veterinary for treatment of thromboembolic disease, pancreatitis, laminitis, endotoxic shock and burns. The treatment of acute phase myocardial infartus, pulmonary embolism, atherosclerosis, deep phlebitis, etc. are amid other applications of heparin sodium.

The product causes potential health effects such as transient eye irritation, hemorrhage at multiple sites, respiratory and kidney abnormalities, anemia, and cardiovascular collapse. Gastrointestinal irritation, nausea, vomiting and diarrhea are also amid the side effects of heparin sodium.

Heparin sodium market is covered in the study Heparin sodium, low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018. The report encompasses proper description of the product, unveils application areas, and briefly summarizes patents in the sphere. It overlooks heparin sodium market situation, names manufacturers, suppliers as well as users. The report also provides current heparin sodium prices in the market.
Skip to top

China Heparin Industry Report, 2015-2018 US$ 2,250.00 Dec, 2015 · 101 pages
Biosimilars: Surveying the Market Landscape US$ 395.00 Oct, 2010 · 75 pages
Acute Coronary Syndrome: Market Research Report US$ 3,450.00 Apr, 2010 · 752 pages

Ask Your Question

Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2018
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: